Overview

Early Sequential Nephron Blockade in Acute Heart Failure Patients: A Randomised, Controlled Study

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study aims to demonstrate the efficacy of sequential nephron blockade by adding hydrochlorothiazide or spironolactone on intravenous furosemide compared to intravenous furosemide alone in the treatments of volume overload in patients with acute heart failure who have diuretic resistance from furosemide stress test.
Phase:
Phase 3
Details
Lead Sponsor:
Chiang Mai University
Treatments:
Hydrochlorothiazide
Spironolactone